{"id":"arxiv:2002.10430","kind":"article","title":"Impact of chronic fetal hypoxia and inflammation on cardiac pacemaker cell development","authors":["Martin G. Frasch","Dino A. Giussani"],"author_count":2,"year":2020,"published":"2020-02-24","venue":"Cells 9(3), 733, 2020","cited_by":15,"doi":"10.3390/cells9030733","arxiv_id":"2002.10430","nct_id":null,"source_url":"https://arxiv.org/abs/2002.10430","archive_url":"https://space-kitty.com/papers/arxiv:2002.10430","updated":"2020-03-20","pmid":null,"pmcid":null,"openalex_id":"W3011772718","pdf_url":"https://arxiv.org/pdf/2002.10430","abstract":"Chronic fetal hypoxia and infection are examples of adverse conditions during complicated pregnancy, which impact cardiac myogenesis and increase the lifetime risk of heart disease. However, the effects that chronic hypoxic or inflammatory environments exert on cardiac pacemaker cells are poorly understood. Here, we review the current evidence and novel avenues of bench-to-bed research in this field of perinatal cardiogenesis as well as its translational significance for early detection of future risk for cardiovascular disease.","abstract_license":"CC0-1.0 (arXiv descriptive metadata)","license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["q-bio.CB","q-bio.SC","q-bio.TO"],"details":null,"provenance":"arxiv","attribution":"Abstract: arXiv descriptive metadata (CC0). Thank you to arXiv for use of its open access interoperability. This service was not reviewed or approved by, nor does it necessarily express or reflect the policies or opinions of, arXiv.","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}